ArticleJournal of eating disorders2023

Correction: Secondary outcomes and qualitative findings of an open-label feasibility trial of lisdexamfetamine dimesylate for adults with bulimia nervosa.

Laura Dixon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.